Neehar D. Parikh

13.1k total citations · 8 hit papers
233 papers, 8.2k citations indexed

About

Neehar D. Parikh is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Neehar D. Parikh has authored 233 papers receiving a total of 8.2k indexed citations (citations by other indexed papers that have themselves been cited), including 171 papers in Hepatology, 121 papers in Epidemiology and 57 papers in Surgery. Recurrent topics in Neehar D. Parikh's work include Hepatocellular Carcinoma Treatment and Prognosis (123 papers), Liver Disease Diagnosis and Treatment (116 papers) and Liver Disease and Transplantation (86 papers). Neehar D. Parikh is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (123 papers), Liver Disease Diagnosis and Treatment (116 papers) and Liver Disease and Transplantation (86 papers). Neehar D. Parikh collaborates with scholars based in United States, United Kingdom and Canada. Neehar D. Parikh's co-authors include Amit G. Singal, Elliot B. Tapper, Jorge A. Marrero, Nicole E. Rich, Adam C. Yopp, Akbar K. Waljee, Anna S. Lok, David W. Hutton, Mobolaji Odewole and Nabihah Tayob and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Neehar D. Parikh

216 papers receiving 8.1k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis

2018 770 citations Nicole E. Rich, Neehar D. Parikh et al. Gastroenterology profile →
Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study

2018 635 citations Elliot B. Tapper, Neehar D. Parikh profile →
Racial and Ethnic Disparities in Nonalcoholic Fatty Liver Disease Prevalence, Severity, and Outcomes in the United States: A Systematic Review and Meta-analysis

2017 339 citations Nicole E. Rich, Neehar D. Parikh et al. Clinical Gastroenterology and Hepatology profile →
HCC surveillance improves early detection, curative treatment receipt, and survival in patients with cirrhosis: A meta-analysis

2022 246 citations Amit G. Singal, Nicole E. Rich et al. Journal of Hepatology profile →
Use of Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis: A Systematic Review and Meta‐Analysis

2020 210 citations Nicole E. Rich, Jorge A. Marrero et al. Hepatology profile →
Diagnosis and Management of Cirrhosis and Its Complications

2023 149 citations Elliot B. Tapper, Neehar D. Parikh profile →
Blood-based biomarkers for hepatocellular carcinoma screening: Approaching the end of the ultrasound era?

2022 98 citations Neehar D. Parikh, Nabihah Tayob et al. Journal of Hepatology profile →
Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment

2024 41 citations Soo Young Hwang, Pojsakorn Danpanichkul et al. Clinical and Molecular Hepatology profile →

Peers

Countries citing papers authored by Neehar D. Parikh

Since Specialization

Citations

This map shows the geographic impact of Neehar D. Parikh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neehar D. Parikh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neehar D. Parikh more than expected).

Fields of papers citing papers by Neehar D. Parikh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Neehar D. Parikh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neehar D. Parikh. The network helps show where Neehar D. Parikh may publish in the future.

Co-authorship network of co-authors of Neehar D. Parikh

This figure shows the co-authorship network connecting the top 25 collaborators of Neehar D. Parikh. A scholar is included among the top collaborators of Neehar D. Parikh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Neehar D. Parikh. Neehar D. Parikh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Downstaging of hepatocellular carcinoma before liver transplantation: Results from a national multicenter prospective cohort study 2025 ·Hepatology ·(unknown), Parissa Tabrizian, Julio R. Gutiérrez, Maarouf Hoteit, Tahereh Ghaziani, Kali Zhou, Neehar D. Parikh, Veeral Ajmera, Elizabeth S. Aby, (unknown), Rebecca Marino, Allison Martin, (unknown), (unknown), Shravan Dave, Sander Florman, Francis Y. Yao, Neil Mehta	3
2	Real‐World Clinical Experience With Sodium Phenylbutyrate and Taurursodiol at a Single Amyotrophic Lateral Sclerosis Center in the United States 2025 ·European Journal of Neurology ·Narghes Calcagno, (unknown), (unknown), (unknown), Sarah Morgan, Neehar D. Parikh, Dylan V. Neel, (unknown), Rebekah Young, (unknown), (unknown), James D. Berry, Sabrina Paganoni	0
3	Patient-Perceived Risk of Hepatocellular Carcinoma and Net Benefit of Surveillance: A Multicenter Survey Study 2025 ·The American Journal of Gastroenterology ·Amit G. Singal, Ju Dong Yang, Prasun K. Jalal, Reena Salgia, Neil Mehta, Maarouf Hoteit, (unknown), Darine Daher, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Jonathan P. Troost, Neehar D. Parikh	1
4	Embolic and Ablative Therapy for Hepatocellular Carcinoma 2024 ·Clinics in Liver Disease ·(unknown), Alisa Likhitsup, Neehar D. Parikh	1
5	Intermediate Term Urinary Outcomes Following Prostate Radiation Therapy after Neoadjuvant Prostate Artery Embolization 2024 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), Ajay Garg, (unknown), Kosj Yamoah, G. Daniel Grass, Neehar D. Parikh	1
6	Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment breakdown → 2024 ·Clinical and Molecular Hepatology ·Soo Young Hwang, Pojsakorn Danpanichkul, Vatche G. Agopian, (unknown), Neehar D. Parikh, Ghassan K. Abou‐Alfa, Amit G. Singal, Ju Dong Yang	41
7	Hepatocellular Carcinoma Screening in a Contemporary Cohort of At-Risk Patients 2024 ·JAMA Network Open ·Darine Daher, (unknown), Nicole E. Rich, Nabihah Tayob, (unknown), Daniel Q. Huang, Ju Dong Yang, Anand V. Kulkarni, Fasiha Kanwal, Jorge A. Marrero, Neehar D. Parikh, Amit G. Singal	12
8	The #HOPE4LIVER Single-Arm Pivotal Trial for Histotripsy of Primary and Metastatic Liver Tumors 2024 ·Radiology ·Mishal Mendiratta‐Lala, Philipp Wiggermann, Maciej Pech, Xavier Serres, Sarah B. White, (unknown), Osman Ahmed, Neehar D. Parikh, (unknown), Maximilian Thormann, Zhen Xu, Zachary Collins, (unknown), Guido Torzilli, Clifford S. Cho, Peter Littler, Tze Min Wah, Luigi Solbiati, Timothy J. Ziemlewicz	29
9	International Liver Cancer Association (ILCA) white paper on hepatocellular carcinoma risk stratification and surveillance 2023 ·Journal of Hepatology ·Amit G. Singal, Marco Sanduzzi‐Zamparelli, Pierre Nahon, Maxime Ronot, Yujin Hoshida, Nicole E. Rich, María Reig, Valérie Vilgrain, Jorge A. Marrero, Josep M. Llovet, Neehar D. Parikh, Augusto Villanueva	51
10	Incidence and Risk Factors for Hepatocellular Carcinoma in Cirrhosis: The Multicenter Hepatocellular Carcinoma Early Detection Strategy (HEDS) Study 2023 ·Gastroenterology ·K. Rajender Reddy, Dale McLerran, Tracey L. Marsh, Neehar D. Parikh, Lewis R. Roberts, Myron Schwartz, (unknown), Alex S. Befeler, (unknown), (unknown), Sudhir Srivastava, Jo Ann Rinaudo, Ziding Feng, Jorge A. Marrero	32
11	Downstaging hepatocellular carcinoma before liver transplantation: A multicenter analysis of the “all-comers” protocol in the Multicenter Evaluation of Reduction in Tumor Size before Liver Transplantation (MERITS-LT) consortium 2023 ·American Journal of Transplantation ·(unknown), Parissa Tabrizian, Maarouf Hoteit, Catherine Frenette, Neehar D. Parikh, Tahereh Ghaziani, Renumathy Dhanasekaran, Jennifer Guy, Amy M. Shui, Sander Florman, Francis Y. Yao, Neil Mehta	9
12	A Phase II Study of Optimized Individualized Adaptive Radiotherapy for Hepatocellular Carcinoma 2023 ·Clinical Cancer Research ·Daniel J. Herr, Chang Wang, Mishal Mendiratta‐Lala, M.M. Matuszak, Charles S. Mayo, Yue Cao, Neehar D. Parikh, Randall K. Ten Haken, Dawn Owen, Joseph R. Evans, (unknown), Michael Yan, Laura A. Dawson, Matthew J. Schipper, Theodore S. Lawrence, Kyle C. Cuneo	3
13	Updates on LI‐RADS Treatment Response Criteria for Hepatocellular Carcinoma: Focusing on MRI 2023 ·Journal of Magnetic Resonance Imaging ·(unknown), Anum Aslam, Neehar D. Parikh, Benjamin M. Mervak, (unknown), (unknown), (unknown), (unknown), (unknown), Mustafa R. Bashir, Richard Kinh Gian, Lauren M. Burke, (unknown), Charles Kim, Kimberly L. Shampain, Dawn Owen, Mishal Mendiratta‐Lala	17
14	Hepatocellular Carcinoma-Related Mortality in the USA, 1999–2018 2022 ·Digestive Diseases and Sciences ·A Ramani, Elliot B. Tapper, (unknown), (unknown), Neehar D. Parikh, Sumeet K. Asrani	12
15	Downstaging Outcomes for Hepatocellular Carcinoma: Results From the Multicenter Evaluation of Reduction in Tumor Size before Liver Transplantation (MERITS-LT) Consortium 2021 ·Gastroenterology ·Neil Mehta, Catherine Frenette, Parissa Tabrizian, Maarouf Hoteit, Jennifer Guy, Neehar D. Parikh, Tahereh Ghaziani, Renumathy Dhanasekaran, Jennifer L. Dodge, (unknown), Matthew L. Holzner, (unknown), Wesley Chan, Austin J. Fobar, Sander Florman, Francis Y. Yao	80
16	Imaging of treatment response during systemic therapy for hepatocellular carcinoma 2021 ·Abdominal Radiology ·William R. Masch, Rony Kampalath, Neehar D. Parikh, (unknown), Anum Aslam, Victoria Chernyak	6
17	Hepatocellular carcinoma tumour volume doubling time: a systematic review and meta-analysis 2020 ·Gut ·(unknown), Purva Gopal, Nicole E. Rich, Adam C. Yopp, Takeshi Yokoo, Binu V. John, Jorge A. Marrero, Neehar D. Parikh, Amit G. Singal	105
18	Surveillance and Monitoring of Hepatocellular Carcinoma During the COVID-19 Pandemic 2020 ·Clinical Gastroenterology and Hepatology ·Neil Mehta, Neehar D. Parikh, Robin Katie Kelley, Bilal Hameed, Amit G. Singal	21
19	Evaluation of AGP Fucosylation as a Marker for Hepatocellular Carcinoma of Three Different Etiologies 2019 ·Scientific Reports ·Jing Liang, Jianhui Zhu, Mengmeng Wang, Amit G. Singal, Mobolaji Odewole, (unknown), (unknown), Suyu Liu, Neehar D. Parikh, David M. Lubman	22
20	Quality of life for donors after living donor liver transplantation: A review of the literature 2010 ·Liver Transplantation ·Neehar D. Parikh, Daniela P. Ladner, Michaël Abécassis, Zeeshan Butt	81

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact